Fangyuan Zhou
- Biomedical Engineering top 1%
- Molecular Biology top 10%
- Immunology top 2%
- Biomaterials top 1%
- Oncology top 5%
- Topics
- Nanoplatforms for cancer theranostics (16 papers)Nanoparticle-Based Drug Delivery (9 papers)Platelet Disorders and Treatments (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Fangyuan Zhou
65 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Biomedical Engineering 2.1k
- Molecular Biology 1.2k
- Immunology 1.1k
- Biomaterials 848
- Oncology 730
Countries citing papers authored by Fangyuan Zhou
This map shows the geographic impact of Fangyuan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyuan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyuan Zhou more than expected).
Fields of papers citing papers by Fangyuan Zhou
This network shows the impact of papers produced by Fangyuan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyuan Zhou. The network helps show where Fangyuan Zhou may publish in the future.
Co-authorship network of co-authors of Fangyuan Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Fangyuan Zhou. A scholar is included among the top collaborators of Fangyuan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyuan Zhou. Fangyuan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 0 | |
| 3 | 10 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 8 | |
| 8 | 3 | |
| 9 | 2 | |
| 10 | 6 | |
| 11 | Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validationbreakdown → | 161 |
| 12 | 12 | |
| 13 | EMT‐associated microRNAs and their roles in cancer stemness and drug resistancebreakdown → | 246 |
| 14 | 9 | |
| 15 | 19 | |
| 16 | 17 | |
| 17 | 7 | |
| 18 | 115 | |
| 19 | 7 | |
| 20 | 52 |
About Fangyuan Zhou
Fangyuan Zhou is a scholar working on Process Chemistry and Technology, Biomaterials and Immunology and Allergy, having authored 71 papers that have together received 3.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (16 papers), Nanoparticle-Based Drug Delivery (9 papers) and Platelet Disorders and Treatments (5 papers). The work is most often cited by research in Biomaterials (848 citations), Immunology (1.1k citations) and Biomedical Engineering (2.1k citations). Fangyuan Zhou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Bing Feng, Haijun Yu, Yaping Li, Dangge Wang, Tingting Wang, Zhiwen Zhang, Yuting Ma, Siling Wang, Yuanlei Fu and Tingting Wang. Their work appears in journals such as Advanced Materials, Nature Communications and Nature Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.